A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond.
Shapira S, Ben Shimon M, Hay-Levi M, Shenberg G, Choshen G, Bannon L, Tepper M, Kazanov D, Seni J, Lev-Ari S, Peer M, Boubas D, Stebbing J, Tsiodras S, Arber N.
Shapira S, et al. Among authors: ben shimon m.
EMBO Mol Med. 2022 Sep 7;14(9):e15997. doi: 10.15252/emmm.202215997. Epub 2022 Jul 13.
EMBO Mol Med. 2022.
PMID: 35776000
Free PMC article.